Gapping up
In reaction to strong earnings/guidance:
- TIF +13.7%, CTRP +2.3%, LOW +1.5%, XCRA +1.5%, ITRN +0.6%
Other news:
- CARA +20.7% (Cara Therapeutics and Vifor Fresenius Medical Care (FMS) Renal Pharma enter into Ex-U.S. licensing agreement to commercialize Korsuva injection), CMTA +5.9% (reports 'positive' data from Part B of the company's ongoing Phase 2 clinical trial evaluating palovarotene for the treatment of patients with fibrodysplasia ossificans progressiva)
- ARCO +4% (announces share repurchase program of up to $60 Million)
- ANW +3.5% (appoints Donald Moore to serve as Chairman and adds three new independent directors; reports 'stable' preliminary Q1 op metrics)
- RMTI +2.9% (Rockwell Medical CEO terminated from position, effective immediately)
- HEAR +2.7% (files for approx 1.86 mln share common stock offering by selling shareholders)
Analyst comments:
- CELG +1% (upgraded to Outperform from Mkt Perform at Bernstein)
